Page last updated: 2024-09-03

celastrol and bms345541

celastrol has been researched along with bms345541 in 1 studies

Compound Research Comparison

Studies
(celastrol)
Trials
(celastrol)
Recent Studies (post-2010)
(celastrol)
Studies
(bms345541)
Trials
(bms345541)
Recent Studies (post-2010) (bms345541)
885174198063

Protein Interaction Comparison

ProteinTaxonomycelastrol (IC50)bms345541 (IC50)
Inhibitor of nuclear factor kappa-B kinase subunit betaHomo sapiens (human)1
Inhibitor of nuclear factor kappa-B kinase subunit alphaHomo sapiens (human)4.54
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)3.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Idris, AI; Krishnan, M; Landao-Bassonga, E; Mollat, P; Ralston, SH; Simic, P; Vukicevic, S1

Other Studies

1 other study(ies) available for celastrol and bms345541

ArticleYear
Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010, Volume: 24, Issue:11

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Resorption; Cell Differentiation; Cell Survival; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Female; Humans; I-kappa B Kinase; Imidazoles; Inhibitory Concentration 50; Mice; Osteoclasts; Ovariectomy; Pentacyclic Triterpenes; Quinoxalines; Sesquiterpenes; Signal Transduction; Triterpenes

2010